Search
01/10/2023
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).
Nadal E, Rodríguez-Abreu D, Simó M, Massutí B, Juan O, Huidobro G, López R, De Castro J, Estival A, Mosquera J, Sullivan I, Felip E, Blasco A, Guirado M, Pereira E, Vilariño N, Navarro V, Bruna J. Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(28)DOI:10.1200/JCO.22.02561. PMID:37603816. IF:42.100(Q1/1D).
01/10/2023
Randomized phase II study of weekly carfilzomib 70 mg/m(2) and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients.
Puertas B, González-Calle V, Sureda A, Moreno MJ, Oriol A, González E, Rosiñol L, López J, Escalante F, Martínez-Lopez J, Carrillo E, Clavero E, Ríos-Tamayo R, Rey-Bua B, González-Rodríguez AP, Dourdil V, De Arriba F, González S, Pérez-de-Oteyza J, Hernández MT, García-Mateo A, Bargay J, Bladé J, Lahuerta JJ, San Miguel JF, Ocio EM, Mateos MV. Randomized phase II study of weekly carfilzomib 70 mg/m(2) and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients.. HAEMATOLOGICA. 2023; 108(10)DOI:10.3324/haematol.2022.282490. PMID:37102598. IF:10.100(Q1/2D).
01/10/2023
Effect of Bypassing the Closest Stroke Center in Patients with Intracerebral Hemorrhage: A Secondary Analysis of the RACECAT Randomized Clinical Trial.
Ramos-Pachón A, Rodríguez-Luna D, Martí-Fàbregas J, Millán M, Bustamante A, Martínez-Sánchez M, Serena J, Terceño M, Vera-Cáceres C, Camps-Renom P, Prats-Sánchez L, Rodríguez-Villatoro N, Cardona-Portela P, Urra X, Solà S, Del Mar Escudero M, Salvat-Plana M, Ribó M, Abilleira S, Pérez de la Ossa N, Silva Y. Effect of Bypassing the Closest Stroke Center in Patients with Intracerebral Hemorrhage: A Secondary Analysis of the RACECAT Randomized Clinical Trial.. JAMA Neurology. 2023; 80(10)DOI:10.1001/jamaneurol.2023.2754. PMID:37603325. IF:20.900(Q1/1D).
01/10/2023
Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy.
Schiava M, Ikenaga C, Topf A, Caballero-Ávila M, Chou TF, Li S, Wang F, Daw J, Stojkovic T, Villar-Quiles R, Nishino I, Inoue M, Nishimori Y, Saito Y, Katsuno M, Noda S, Ito C, Otsuka M, Nahir S, Manousakis G, Walk D, Quinn C, Alfano L, Sahenk Z, Tasca G, Monforte M, Sabatelli M, Bisogni G, Oldfors A, Rydeliu A, Pal E, Paradas C, Velez B, De Bleecker JL, Farugia ME, Longman C, Harms MB, Ralston S, Zanoteli E, Macedo Serafim da Silva A, Sotoca J, Juntas-Morales R, Bevilacqua J, Balart M, Talbot S, Straub V, Guglieri M, Marini-Bettolo C, Diaz-Manera J, Weihl CC. Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy.. Neurology-Genetics. 2023; 9(5)DOI:10.1212/NXG.0000000000200093. PMID:37588275. IF:(Q/D).
01/10/2023
The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes.
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Robles NR, Agraz I, Poch E, Rodas L, Lozano V, Fernández-Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García-Fernández N, Goicoechea M, Calero F, Bonet J, Liaño F, Pascual J, Bestard O, Praga M, Fulladosa X, Soler MJ. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes.. Clinical Kidney Journal. 2023; 16(10)DOI:10.1093/ckj/sfad142. PMID:37779839. IF:(Q/D).
01/10/2023
GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations.
Xie F, Shemilt I, Vale L, Ruiz F, Drummond MF, Lord J, Herrmann KH, Rojas MX, Zhang Y, Canelo-Aybar C, Alonso-Coello P, Shamliyan T, Schünemann HJ. GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations.. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2023; 162DOI:10.1016/j.jclinepi.2023.08.001. PMID:37597696. IF:7.300(Q1/1D).
01/10/2023
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review.
Girolomoni G, Savage L, Gisondi P, Svensson Å, Mahé E, Augustin M, Puig L. Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review.. Dermatology and Therapy. 2023; 13(10)DOI:10.1007/s13555-023-01014-x. PMID:37710078. IF:3.500(Q1/3D).
01/10/2023
The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study.
Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Stratigos A, Trakatelli M, Puig L. The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study.. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37 Suppl 7DOI:10.1111/jdv.18916. PMID:37806003. IF:8.500(Q1/1D).
01/10/2023
Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project.
Gisondi P, Puig L, Richard MA, Paul C, Nijsten T, Taieb C, Stratigos A, Trakatelli M, Salavastru C. Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project.. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37 Suppl 7DOI:10.1111/jdv.18917. PMID:37806002. IF:8.500(Q1/1D).
01/10/2023
Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP).
Goni-Fuste B, Pergolizzi D, Monforte-Royo C, Alonso-Babarro A, Belar A, Crespo I, Güell E, Julià-Torras J, Moreno-Alonso D, Nabal Vicuña M, Pascual A, Porta-Sales J, Rocafort J, Rodríguez-Prat A, Rodríguez D, Sala C, Serrano-Bermúdez G, Serna J, Balaguer A. Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP).. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2023; 66(4)DOI:10.1016/j.jpainsymman.2023.07.011. PMID:37468050. IF:3.200(Q1/2D).
01/10/2023
Open versus robotic-assisted kidney transplantation: A systematic review by the European Association of Urology (EAU) - Young Academic Urologists (YAU) Kidney Transplant Working Group.
Territo A, Bajeot AS, Mesnard B, Campi R, Pecoraro A, Hevia V, Piana A, Doumerc N, Breda A, Boissier R, Prudhomme T. Open versus robotic-assisted kidney transplantation: A systematic review by the European Association of Urology (EAU) - Young Academic Urologists (YAU) Kidney Transplant Working Group.. Actas Urologicas Espanolas. 2023; 47(8)DOI:10.1016/j.acuroe.2023.03.003. PMID:36965855. IF:(Q/D).
01/10/2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy.
Piszczek R, Krajewski W, Subiela JD, Del Giudice F, Nowak L, Chorbinska J, Moschini M, Masson-Lecomte A, Bebane S, Cimadamore A, Grobet-Jeandin E, Rouprêt M, D'Andrea D, Mastroianni R, Gutierrez Hidalgo B, Gomez Rivas J, Mori K, Soria F, Laukhtina E, Mari A, Albisinni S, Gallioli A, Mertens LS, Pichler R, Marcq G, Laszkiewicz J, Halon A, Carrion DM, Akand M, Pradere B, Shariat SF, Palou J, Babjuk M, Burgos Revilla J, Malkiewicz B, Szydelko T. Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy.. Minerva Urology And Nephrology. 2023; 75(5)DOI:10.23736/S2724-6051.23.05418-6. PMID:37728495. IF:4.900(Q1/2D).
01/10/2023
Unveiling the impact of stone disease: enhancing quality of life through comprehensive care.
Esperto F, Pietropaolo A, Emiliani E, DE Coninck V, Tailly T, Keller EX, Talso M, Tonyali S, Sener ET, Zeesha Nhameed BM, Tzelves L, Ventimiglia E, Juliebø-Jones P, Faiella E, Mykoniatis I, Tsaturyan A, Scarpa RM. Unveiling the impact of stone disease: enhancing quality of life through comprehensive care.. Minerva Urology And Nephrology. 2023; 75(5)DOI:10.23736/S2724-6051.23.05537-4. PMID:37728501. IF:4.900(Q1/2D).
01/10/2023
Comment on: "Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy".
Asero V, Scornajenghi CM, Carino D, Pandolfo SD, Krajewski W, Gallioli A, Basran S, Tresh A, Chung BI, Del Giudice F. Comment on: "Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy".. Minerva Urology And Nephrology. 2023; 75(5)DOI:10.23736/S2724-6051.23.05529-5. PMID:37530677. IF:4.900(Q1/2D).
01/10/2023
3'IsomiR Species Composition Affects Reliable Quantification of miRNA/isomiR Variants by Poly(A) RT-qPCR: Impact on Small RNA-Seq Profiling Validation
Ferre, A, Santiago, L, Sánchez-Herrero, JF, López-Rodrigo, O, Sánchez-Curbelo, J, Sumoy, L, Bassas, L, Larriba, S. 3'IsomiR Species Composition Affects Reliable Quantification of miRNA/isomiR Variants by Poly(A) RT-qPCR: Impact on Small RNA-Seq Profiling Validation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(20)DOI:10.3390/ijms242015436. PMID:37895116. IF:4.900(Q1/3D).
01/10/2023
Applications of artificial intelligence in nutrition and dietetics: Beyond virtual assistants
Bonilla, DA, Daga, R, Gamero, A, Pérez-López, A, Pérez-Esteve, E, Pérez-Armijo, P, Petermann-Rocha, F, Lozano-Lorca, M, García-Galbis, MR, Kouiti, M, Carrillo-Alvarez, E, Fernández-Villa, T, Apolinar-Jiménez, E, Nava-González, EJ, Benítez-Brito, N, Almendra-Regueros, R. Applications of artificial intelligence in nutrition and dietetics: Beyond virtual assistants. Revista Espanola De Nutricion Humana Y Dietetica. 2023; 27(4)DOI:10.14306/renhyd.27.4.2054. PMID:. IF:(Q/D).
01/10/2023
Pros and cons of open science from the Spanish Journal of Human Nutrition and Dietetics
Pérez-López, A, Fernández-Villa, T, Lozano-Lorca, M, Pérez-Armijo, P, García-Galbis, MR, Pérez-Esteve, E, Gamero, A, Petermann-Rocha, F, Apolinar-Jiménez, E, Nava-González, EJ, Almendra-Pegueros, R. Pros and cons of open science from the Spanish Journal of Human Nutrition and Dietetics. Revista Espanola De Nutricion Humana Y Dietetica. 2023; 27(4)DOI:10.14306/renhyd.27.4.2055. PMID:. IF:(Q/D).
01/10/2023
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions.
de Mendoza C, Rando A, Miró E, Pena MJ, Rodríguez-Avial I, Ortega D, González-Praetorius A, Reina G, Pintos I, Pozuelo MJ, Soriano V. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions.. JOURNAL OF CLINICAL VIROLOGY. 2023; 167DOI:10.1016/j.jcv.2023.105578. PMID:37660433. IF:4.000(Q2/4D).
01/10/2023
Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus
Crespo-Lessmann A., Marqués-Espi J.A., Dominguez-Ortega J., Perez de Llano L., Blanco-Aparicio M., Santiñá M., Palop-Cervera M., Álvarez F.J., Fraj J.. Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus. Journal Of Healthcare Quality Research. 2023; 38(5)DOI:10.1016/j.jhqr.2023.03.003. PMID:37003928. IF:(Q/D).
01/10/2023
Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries
Martínez-García M.Á., Oscullo G., Gómez-Olivas J.D., Olveira C., Girón R., García-Clemente M., Máiz L., Sibila O., Golpe R., Rodríguez-Hermosa J.L., Barreiro E., Méndez R., Prados C., Rodríguez-López J., De La Rosa D.. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(10)DOI:10.1016/j.arbres.2023.07.023. PMID:37563019. IF:(Q/D).